Search results
Drug targeting clear cell renal cell carcinoma shows promising approach
Newswise· 1 day agoApril 23, 2024 – In a groundbreaking phase one clinical trial led by UT Southwestern Medical Center,...
Signs and Symptoms of Kidney Cancer
Health via Yahoo News· 6 days agoIn fact, kidney cancer is often found accidentally during a routine physical or imaging exam, such as an X-ray or MRI. There are three main types of kidney cancers: renal ...
New trial shows immunotherapy post-surgery improves overall survival for kidney cancer
Medical Xpress· 7 days agoTreatment with pembrolizumab, an immunotherapy drug, after surgery significantly prolonged overall...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 5 days agoPatients will receive Keytruda or Keytruda plus the vaccine after bladder or kidney removal. Bladder...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 2 days agoInvestor focus is likely to be on the sales of Merck's (MRK) blockbuster oncology medicine,...
Nisa Investment Advisors LLC Boosts Stock Position in Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
ETF DAILY NEWS· 2 days agoNisa Investment Advisors LLC raised its stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Free Report) by 284.0% in the 4th quarter, according to the company in its most recent ...
Strs Ohio Raises Holdings in Exelixis, Inc. (NASDAQ:EXEL)
ETF DAILY NEWS· 4 days agoStrs Ohio raised its position in Exelixis, Inc. (NASDAQ:EXEL – Free Report) by 9.2% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned ...
Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AML
Morningstar· 2 days agoKura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that its ...
BeiGene (NASDAQ:BGNE) Trading Down 2.4%
ETF DAILY NEWS· 3 days agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report)’s stock price dropped 2.4% during trading on Friday . The company traded as low as $126.97 and last traded at $128.77. Approximately 17,319 shares ...
Analysts Set BeiGene, Ltd. (NASDAQ:BGNE) PT at $251.70
ETF DAILY NEWS· 2 days agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the stock, MarketBeat Ratings reports ...